Advertisement

Topics

New Cancer Drugs With No Benefit 'Should Be Withdrawn'

03:49 EST 1 Dec 2016 | Medscape

Many new cancer drugs were approved by the FDA on the basis of preliminary surrogate endpoints, and postmarketing studies do not support any real benefit.
Medscape Medical News

Original Article: New Cancer Drugs With No Benefit 'Should Be Withdrawn'

NEXT ARTICLE

More From BioPortfolio on "New Cancer Drugs With No Benefit 'Should Be Withdrawn'"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...